J. Christopher Naftzger - Net Worth and Insider Trading

J. Christopher Naftzger Net Worth

The estimated net worth of J. Christopher Naftzger is at least $0 dollars as of 2024-11-13. J. Christopher Naftzger is the General Counsel and Corp Sec of Nabriva Therapeutics PLC and owns about 280 shares of Nabriva Therapeutics PLC (NBRVF) stock worth over $0. Details can be seen in J. Christopher Naftzger's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that J. Christopher Naftzger has not made any transactions after 2021-12-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of J. Christopher Naftzger

To

J. Christopher Naftzger Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, J. Christopher Naftzger owns 2 companies in total, including Nabriva Therapeutics PLC (NBRVF) , and Arbutus Biopharma Corp (ABUS) .

Click here to see the complete history of J. Christopher Naftzger’s form 4 insider trades.

Insider Ownership Summary of J. Christopher Naftzger

Ticker Comapny Transaction Date Type of Owner
NBRVF Nabriva Therapeutics PLC 2021-12-27 General Counsel and Corp Sec
ABUS Arbutus Biopharma Corp 2023-07-10 General Counsel and CCO

J. Christopher Naftzger Latest Holdings Summary

J. Christopher Naftzger currently owns a total of 1 stock. J. Christopher Naftzger owns 280 shares of Nabriva Therapeutics PLC (NBRVF) as of December 27, 2021, with a value of $0.

Latest Holdings of J. Christopher Naftzger

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NBRVF Nabriva Therapeutics PLC 2021-12-27 280 0.00 0

Holding Weightings of J. Christopher Naftzger


J. Christopher Naftzger Form 4 Trading Tracker

According to the SEC Form 4 filings, J. Christopher Naftzger has made a total of 1 transactions in Nabriva Therapeutics PLC (NBRVF) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Nabriva Therapeutics PLC is the acquisition of 280 shares on December 27, 2021, which cost J. Christopher Naftzger around $4,130.

Insider Trading History of J. Christopher Naftzger

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

J. Christopher Naftzger Trading Performance

GuruFocus tracks the stock performance after each of J. Christopher Naftzger's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by J. Christopher Naftzger is -16.12%. GuruFocus also compares J. Christopher Naftzger's trading performance to market benchmark return within the same time period. The performance of stocks bought by J. Christopher Naftzger within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how J. Christopher Naftzger's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of J. Christopher Naftzger

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -22.59 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -12.89 LIMIT LIMIT LIMIT LIMIT LIMIT

J. Christopher Naftzger Ownership Network

Ownership Network List of J. Christopher Naftzger

No Data

Ownership Network Relation of J. Christopher Naftzger

Insider Network Chart

J. Christopher Naftzger Owned Company Details

What does Nabriva Therapeutics PLC do?

Who are the key executives at Nabriva Therapeutics PLC?

J. Christopher Naftzger is the General Counsel and Corp Sec of Nabriva Therapeutics PLC. Other key executives at Nabriva Therapeutics PLC include Chief Executive Officer Hogan H Michael Iii , Chief Financial Officer David Maggio , and Chief Executive Officer Broom Colin Md .

Nabriva Therapeutics PLC (NBRVF) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Nabriva Therapeutics PLC (NBRVF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nabriva Therapeutics PLC (NBRVF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Nabriva Therapeutics PLC (NBRVF)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nabriva Therapeutics PLC Insider Transactions

No Available Data

J. Christopher Naftzger Mailing Address

Above is the net worth, insider trading, and ownership report for J. Christopher Naftzger. You might contact J. Christopher Naftzger via mailing address: 633 Lowther Road, Lewisberry Pa 17339.